MEET DIPANJAN CHOWDHURY, PHD
MEET TINA’S WISH RESEARCHER DIPANJAN CHOWDHURY, PhD Dipanjan Chowdhury, PhD is Chief of the Division of Radiation and Genomic Stability in the Department… View more
Noninvasive ovarian cancer biomarker detection via an optical nanosensor implant
Through their collaborative efforts, Tina’s Wish Researchers, Daniel Heller, PhD, MSKCC, Ryan Williams, PhD, MSKCC and Douglas Levine, NYU Langone Medical Center… View more
Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer
“Wistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for the… View more
2018 JUNIOR ADVISORY BOARD TRIVIA NIGHT
The Tina’s Wish Junior Advisory Board hosted their third annual Trivia Night on March 15th at the Cutting Room. 188 guests enjoyed… View more
Living with ovarian cancer as a chronic disease — and celebrating milestones
Joan Janssen, an ovarian cancer patient at Dana-Farber, speaks about the development of targeted therapies and how she is using them to… View more
NEW BLOOD TEST DEVELOPED TO DIAGNOSE OVARIAN CANCER
Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute, including Tina’s Wish researchers, Dipanjan Chowdhury, PhD, and Kevin Elias, MD, are… View more